Table 1. Clinicopathological characteristics (N=298).
HS3ST2 hypermethylation |
||||
---|---|---|---|---|
Category | Subcategory | No (N=203) | Yes (N=95) | P-value |
Agea | 62 ± 8 | 60 ± 11 | 0.12 | |
Pack-yearsa | 26 ± 24 | 32 ± 25 | 0.01 | |
Size (cm)a | 3.9 ± 1.9 | 4.3 ± 2.1 | 0.14 | |
Sex | Women | 45 | 26 | |
Men | 158 | 69 | 0.33 | |
Smoking status | Never | 73 | 15 | |
Former | 32 | 17 | ||
Current | 98 | 63 | 0.002 | |
Histology | Adenob | 77 | 48 | |
Squamousb | 107 | 39 | ||
Others | 19 | 8 | 0.12 | |
Differentiationc | Well | 25 | 17 | |
Moderately | 95 | 37 | ||
Poorly | 29 | 18 | ||
Undifferentiated | 7 | 2 | 0.31 | |
Pathologic stage | I | 118 | 58 | |
II | 53 | 19 | ||
III | 30 | 17 | ||
IV | 2 | 1 | 0.66 | |
Recurrence | No | 110 | 59 | |
Yes | 93 | 36 | 0.20 |
Mean ± standard deviation
Adeno, adenocarcinoma; squamous, squamous cell carcinoma
Differentiation data are missing in 68 cases